NCT03708887View on ClinicalTrials.gov

The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

415

Participants

Timeline

Start Date

October 10, 2020

Primary Completion Date

January 2, 2022

Study Completion Date

February 28, 2022

Conditions
Hyperglycaemia (Diabetic)Hyperlipidemias
Interventions
DRUG

Low dose omega-3 fatty acid supplementation

Omega-3 fatty acids capsules, 1.5 g/d by mouth for 1 year

DRUG

High dose omega-3 fatty acid supplementation

Omega-3 fatty acids capsules, 3 g/d by mouth for 1 year

DRUG

Control drug

Matching placebo capsules,3 g/d by mouth for 1 year

Trial Locations (1)

321102

Lanxi Red Cross Hospital, Jinhua

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT03708887 - The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients | Biotech Hunter | Biotech Hunter